Replies to post #195266 on Anavex Life Sciences Corp (AVXL)

[Lima4918]

GNCA promising results in phase 1/2 on 5 patients equals $1.1B MC.
Merck paid $1B last week for a phase 2 that was "intriguing"
This is a sign to all of us about what's about to happen to our share price here.